Cancer Family
Urinary System Neoplasm
CI-CAN-00000379Explore in graph →
Non-malignant964 active trials28 approved drugs109 evidence items
- NCIt
- C3431
Loading cancer entity…
Cancer Family
CI-CAN-00000379Explore in graph →
Clinical trials
4,238 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00025103 | Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | unknown | Phase 2 | 75 | Children's Cancer and Leukaemia GroupOTHER | 2 | Aug 2, 2013 | clinicaltrials |
| NCT01246817 | Temsirolimus-RCC-imaging | unknown | Phase 2 | 51 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00633204 | Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer | unknown | Phase 2 | 150 | Iwate Medical UniversityOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT01069770 | Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC) | unknown | Phase 2 | 32 | Korean Urological Oncology SocietyOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT01219751 | Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma | unknown | Phase 2 | 35 | Asan Medical CenterOTHER | 1 | Jun 17, 2011 | clinicaltrials |
| NCT01196403 | Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer | unknown | Phase 2 | 92 | Wales Cancer Trials UnitOTHER | 1 | Apr 1, 2011 | clinicaltrials |
| NCT00862303 | DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 100 | Fuzhou General HospitalOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT01240005 | Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Qingdao UniversityOTHER | 1 | Nov 15, 2010 | clinicaltrials |
| NCT00610389 | Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 2 | 27 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT01041482 | A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma(AGuo) | unknown | Phase 2 | 140 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT01000129 | Adaptive Planning in Bladder Cancer(APPLY) | unknown | Phase 2 | 32 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00740441 | A Phase II Study of AS1411 in Renal Cell Carcinoma | unknown | Phase 2 | 30 | Antisoma ResearchINDUSTRY | 1 | Sep 25, 2009 | clinicaltrials |
| NCT00890110 | Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib(rcc) | unknown | Phase 1 / Phase 2 | 13 | Hadassah Medical OrganizationOTHER | 0 | Apr 29, 2009 | clinicaltrials |
| NCT00816075 | Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection | unknown | Phase 2 / Phase 3 | 40 | Bozyaka Training and Research HospitalOTHER | 1 | Feb 17, 2009 | clinicaltrials |
| NCT00818350 | Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer | unknown | Phase 1 / Phase 2 | 25 | Campania Younger Oncologists AssociationOTHER | 0 | Jan 7, 2009 | clinicaltrials |
| NCT00006118 | Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00024388 | Chemotherapy in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00039169 | BAY 59-8862 in Treating Patients With Advanced Kidney Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 24, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Aug 2, 2013source: clinicaltrials